Olecranon bursitis

1. High-Yield Summary

Olecranon bursitis is one of the most common superficial entheseal inflammatory conditions encountered in orthopaedic practice. Successful clinical management hinges on rapid differentiation between aseptic and septic etiologies, adherence to safe procedural techniques, and evidence-based surgical decision-making:

• Critical Clinical Differentiation: Septic olecranon bursitis and septic arthritis of the elbow joint represent distinct clinical emergencies. Isolated olecranon bursitis demonstrates preserved, painless passive elbow pronation, supination, and gentle mid-arc flexion-extension, whereas elbow joint septic arthritis produces agonizing restriction in all planes of motion with pronounced fullness and tenderness centered at the lateral soft spot (olecranon-radial head-lateral epicondyle triangle).
• Sterile Lateral Aspiration Corridor: When diagnostic or therapeutic bursal aspiration is indicated, the needle must enter strictly through healthy lateral skin. Aspiration through the thinned, inflamed posterior midline directly over the olecranon apex creates a non-healing sinus tract and chronic cutaneous fistula.
• Diagnostic Fluid Thresholds: Bursal fluid leukocyte count greater than 10,000 to 50,000/mcL with more than 80% to 90% polymorphonuclear leukocytes (PMNs) strongly indicates septic bursitis, predominantly driven by Staphylococcus aureus (>80% of culture-positive cases). Polarized microscopy is essential to identify monosodium urate (gout) or calcium pyrophosphate dihydrate (pseudogout) crystals.
• Corticosteroid Hazards: Intrabursal corticosteroid injection provides short-term symptom relief in aseptic cases but carries a high complication rate (10% to 38%), including localized dermal atrophy, hypopigmentation, chronic sinus tract formation, and iatrogenic bacterial seeding. First-line management of aseptic bursitis relies on compressive wrapping, cryotherapy, NSAIDs, and mechanical protection.
• Surgical Principles: Operative bursectomy for refractory or complicated cases requires a gently curved posterolateral incision to preserve the tenuous posterior cutaneous vascularity and avoid a painful scar directly on the bony prominence. Level I randomized trial evidence confirms that primary 1-stage bursectomy with closed suction drainage matches the cure rate of traditional 2-stage open debridement while significantly shortening hospital stay.

2. Applied Surgical Anatomy & Danger Zones

Understanding the microvascular, neural, and tendinous architecture surrounding the posterior elbow is mandatory to achieve successful bursectomy without wound breakdown, nerve injury, or extensor mechanism compromise.

Anatomy of the Subcutaneous Olecranon Bursa

The subcutaneous olecranon bursa is an acquired synovial-lined potential space situated between the dorsal cutaneous envelope and the posterior osseous surface of the olecranon process and distal triceps tendon. It is functionally designed to reduce friction during elbow flexion and extension through an arc of 0 to 145 degrees. A second, deeper bursa (the subtendinous olecranon bursa) lies deep to the triceps tendon, situated between the tendon and the posterior elbow joint capsule. Pathology involving the subcutaneous bursa is distinct from subtendinous inflammation, which presents with deep posterior joint pain rather than visible exophytic swelling.

Triceps Tendon Insertion and Subperiosteal Boundary

The triceps brachii tendon inserts broadly into the posterior third of the proximal olecranon process over a rectangular footprint measuring approximately 1.5 cm in width and 1.0 to 1.5 cm in length. The tendon fibers blend intimately with the deep wall of the subcutaneous olecranon bursa and the underlying periosteum. During operative excision of the bursa, dissection must remain strictly superficial to the triceps tendon fibers. Stripping or sharply dividing the tendinous insertion destabilizes the extensor mechanism, predisposing to avulsion or persistent extensor lag.

Neurovascular Danger Zones and Medial Ulnar Corridor

The primary neurological danger zone during olecranon bursectomy is the ulnar nerve:

• Cubital Tunnel Corridor: The ulnar nerve traverses the postero-medial aspect of the elbow, entering the cubital tunnel posterior to the medial epicondyle. At the level of the olecranon tip, the nerve lies a mere 1.5 to 2.5 cm medial to the osseous apex when the elbow is extended, and shifts slightly anteriorly during flexion.
• Medial Retraction and Portal Hazards: Overzealous medial dissection, blind electrocautery, aggressive retractor placement, or misplaced medial endoscopic portals risk direct ulnar nerve laceration, thermal coagulation, or traction neuropraxia. In patients with preexisting subluxation of the ulnar nerve, the nerve can ride directly over the medial epicondyle into the operative field.
• Cutaneous Nerve Branches: Distal branches of the medial antebrachial cutaneous nerve and the posterior antebrachial cutaneous nerve cross the medial and lateral borders of the bursa, respectively. Transection can lead to painful cutaneous neuromas or localized hypoesthesia.

Posterior Cutaneous Microvascular Perfusion

The cutaneous envelope over the posterior olecranon process is uniquely vulnerable to ischemia. It receives blood supply from the olecranon arterial network (rete olecrani), an anastomotic arcade formed by terminal branches of the superior and inferior ulnar collateral arteries, the posterior ulnar recurrent artery, the radial collateral artery, and the interosseous recurrent artery. The overlying skin is thin, possesses minimal subcutaneous adipose padding, and experiences intense tension and shearing forces during elbow flexion. Surgical incisions placed directly on the posterior midline experience maximum mechanical tension across the bony prominence, predisposing to skin necrosis, wound edge dehiscence, and chronic fistulization.

3. Pathogenesis & Biofilm Microbiology

Olecranon bursitis arises through three distinct pathophysiological mechanisms: mechanical trauma, crystalline deposition, and bacterial inoculation.

Biomechanical Microtrauma and Friction

Aseptic bursitis most frequently results from acute blunt trauma (such as a direct fall onto the posterior elbow) or chronic repetitive mechanical friction. Repetitive weight-bearing or resting of the elbows on hard surfaces (seen in draftsmen, students, miners, carpet layers, and mechanics) triggers microvascular injury, endothelial activation, and synovial hypersecretion. The synovial lining responds with cellular hypertrophy, fibrinous exudate generation, and proliferation of fibrous connective tissue. Over time, persistent shear forces promote internal trabeculation, wall thickening, and the formation of corpora oryzoidea (“rice bodies”), which represent shed necrotic synovial nodules encased in fibrin.

Crystalline Microdeposition

Metabolic and systemic inflammatory disorders frequently manifest in the olecranon bursa:

• Gout (Monosodium Urate): Due to the lower peripheral tissue temperature and repetitive microtrauma, monosodium urate crystals precipitate within the bursal fluid and synovial lining. This induces a vigorous neutrophil-driven inflammatory response mediated by the NLRP3 inflammasome and interleukin-1 beta (IL-1beta). Chronic untreated hyperuricemia produces large chalky tophi that erode the overlying dermis.
• Pseudogout (Calcium Pyrophosphate Dihydrate): CPPD crystal deposition produces acute or subacute bursal inflammation that closely mimics acute septic bursitis.
• Rheumatoid Arthritis and Renal Osteodystrophy: Rheumatoid nodules, chronic proliferative pannus, and dystrophic calcifications from secondary hyperparathyroidism in end-stage renal disease (ESRD) can establish chronic recurrent bursal distension.

Septic Inoculation and Biofilm Microbiology

The superficial anatomical location and thin protective integument render the olecranon bursa vulnerable to bacterial colonization:

• Mechanism of Inoculation: Direct transcutaneous inoculation occurs through microabrasions, lacerations, skin fissures, insect bites, or therapeutic needle punctures. Alternatively, local cellulitis can spread via retrograde dermal lymphatics into the bursal cavity. Hematogenous seeding is distinctly rare.
• Microbiological Spectrum: Over 80% of all culture-positive septic olecranon bursitis cases are caused by Staphylococcus aureus, with a rising prevalence of community-acquired methicillin-resistant S. aureus (CA-MRSA). The second most frequent pathogens are Streptococcus pyogenes (Group A beta-hemolytic Streptococcus) and other streptococcal species (accounting for 10% to 15%). Gram-negative bacilli (such as Pseudomonas aeruginosa or Escherichia coli) and fungal organisms occur primarily in immunocompromised individuals, diabetic patients, or intravenous drug users. Atypical mycobacterial infections (e.g., Mycobacterium marinum) must be suspected following marine or aquarium exposure.
• Biofilm Formation and Tissue Compromise: S. aureus rapidly expresses surface adhesins and secretes an extracellular polymeric substance, establishing a biofilm on the bursal wall and any adjacent osteophytic spurs. This biofilm shields bacteria from host phagocytes and systemic antibiotic penetration, promoting recurrent infection and spontaneous skin perforation if surgical debridement is delayed.

4. Natural History & Epidemiology

Olecranon bursitis displays distinct demographic predilections and recognizable clinical trajectories depending on host factors and underlying etiology.

Demographic Distribution and Occupational Risk Factors

Olecranon bursitis accounts for approximately one-third of all soft-tissue bursitis presentations. It exhibits a pronounced male predominance (male-to-female ratio of roughly 3:1 to 4:1), most frequently affecting individuals aged 20 to 60 years. Occupational hazards involving prolonged leaning on the elbows (miners, plumbers, carpet layers, students, truck drivers) and participation in contact sports (football, rugby, wrestling) represent major predisposing factors. Systemic conditions including diabetes mellitus, chronic kidney disease (particularly patients undergoing hemodialysis), rheumatoid arthritis, gout, chronic alcoholism, and systemic immunosuppression markedly increase susceptibility to both spontaneous bursal inflammation and secondary bacterial infection.

Clinical Progression and Untreated Sequelae

Acute traumatic aseptic bursitis typically resolves over 2 to 4 weeks with conservative therapy, although failure to modify biomechanical pressure leads to chronic fibrotic thickening. In contrast, untreated septic olecranon bursitis follows a destructive clinical course:

• Peribursal Phlegmon and Skin Necrosis: Uncontrolled purulent distension elevates intraluminal pressure, compromising the already fragile dermal microvasculature. Spontaneous skin perforation occurs, yielding a chronic discharging cutaneous sinus or extensive skin sloughing.
• Olecranon Osteomyelitis: Prolonged infectious contact can cause direct bacterial penetration through the cortical bone, resulting in contiguous osteomyelitis of the olecranon process.
• Intra-articular Extension: Although the dense posterior elbow capsule provides a robust mechanical barrier, chronic purulent enzyme degradation can breach the capsule, converting isolated extra-articular bursitis into devastating intra-articular septic arthritis of the ulnohumeral joint.

5. Clinical Presentation

A meticulous clinical evaluation is paramount to establish an accurate diagnosis and prevent catastrophic mischaracterization of septic bursitis as simple aseptic trauma.

Patient History

The clinician must interrogate specific historical parameters:

• Onset and Trajectory: Sudden, explosive onset within 24 to 48 hours accompanied by severe throbbing pain suggests septic or acute crystalline bursitis. Indolent, progressive, painless swelling over weeks to months indicates chronic mechanical aseptic bursitis.
• Skin Integrity and Inoculation Events: Ask specifically about antecedent minor trauma, superficial abrasions, puncture wounds, insect bites, or recent bursal injections or aspirations.
• Systemic Symptoms: Note fevers, rigors, night sweats, or fatigue. Over 40% to 50% of patients with culture-proven septic olecranon bursitis remain entirely afebrile; the absence of systemic fever does not rule out bacterial sepsis.
• Medical Comorbidities: Document any history of hyperuricemia, inflammatory arthropathy, diabetes mellitus, or chronic immunosuppression.

Physical Examination Maneuvers

Physical examination must systematically evaluate the cutaneous envelope, bursal margins, and the underlying elbow joint:

• Inspection and Palpation: A discrete, fluctuant “goose egg” swelling over the posterior olecranon tip is characteristic. Assess for localized calor, erythema, surrounding peribursal cellulitis, and draining sinus tracts. Palpate for subcutaneous gouty tophi, rheumatoid nodules, or firm internal rice bodies.
• Passive Flexion Skin-Stretch Test: The examiner gently and slowly brings the elbow into passive flexion beyond 90 degrees. Discomfort localized strictly to the thinned posterior skin envelope over the distended bursa without deep joint pain indicates superficial extra-articular pathology [Sensitivity 89%, Specificity 84%].
• Lateral Soft Spot Palpation Maneuver: The examiner palpates the soft-tissue triangle defined by the lateral epicondyle, olecranon tip, and radial head. A soft, non-tender depression confirms an isolated extra-articular olecranon bursal effusion, whereas tense bulging, tenderness, and ballotable fluid indicate a true intra-articular elbow joint effusion [Sensitivity 92%, Specificity 88%].
• Axial Joint Compression Test: An axial compressive force is applied through the patient’s forearm into the extended or slightly flexed elbow joint. Marked deep articular pain indicates intra-articular arthritis or chondral injury, whereas absence of pain confirms that the pathology is confined to the extra-articular bursal space [Sensitivity 85%, Specificity 91%].

Comparative Diagnostic Differentiation

Accurate differentiation between aseptic bursitis, septic bursitis, and true intra-articular septic arthritis is the single most critical diagnostic objective:

6. Imaging and Diagnostic Studies

Diagnostic imaging and fluid analysis form an integrated diagnostic pathway to confirm bursal pathology and exclude joint involvement or bone infection.

Plain Radiography

Standard plain radiographs (anteroposterior, lateral, and axial olecranon views) represent the mandatory initial imaging modality:

• Soft-Tissue Envelope: The lateral projection visualizes prominent posterior soft-tissue shadow and swelling over the olecranon process without an anterior or posterior fat pad sign. A displaced anterior fat pad (“sail sign”) or visible posterior fat pad indicates an intra-articular elbow effusion, pointing toward septic arthritis or intra-articular fracture rather than isolated bursitis.
• Osseous Landmarks and Spurs: Identify traction enthesophytes or osteophytes at the triceps insertion, which occur in 20% to 30% of chronic cases. A prominent, sharp spur produces chronic focal mechanical irritation and must be addressed if bursectomy is undertaken.
• Exclusion of Osteomyelitis and Foreign Bodies: Scrutinize the cortical margin of the olecranon. Cortical irregularity, osteolysis, or periosteal reaction indicates contiguous olecranon osteomyelitis. Detect radiopaque foreign bodies (glass, metal, gravel) that may have seeded the bursa.

Diagnostic Musculoskeletal Ultrasound

High-frequency linear ultrasound (10 to 15 MHz) provides real-time bedside evaluation:

• Fluid Characteristics and Synovial Architecture: Visualizes anechoic fluid in simple traumatic effusions, or complex hypoechoic fluid with internal echogenic debris and thick septations in chronic or septic bursitis. Power Doppler demonstrates intense peribursal and synovial hyperemia in active infectious or crystalline inflammation.
• Crystalline Features: Gout demonstrates the classic “double contour sign” on the superficial bony surface or punctate hyperechoic foci with acoustic shadowing corresponding to tophi.
• Ultrasound-Guided Aspiration: Allows precise needle positioning within loculated collections while actively visualizing and avoiding adjacent neurovascular structures and the triceps tendon.

Advanced Cross-Sectional Imaging

Magnetic resonance imaging (MRI) is rarely required for routine olecranon bursitis but is indicated when clinical presentation raises concern for deep subfascial infection, contiguous osteomyelitis, or diagnostic ambiguity. MRI demonstrates a well-circumscribed, T1-hypointense, T2/STIR-hyperintense fluid collection in the subcutaneous space. Post-contrast fat-suppressed T1 sequences show thick peripheral ring enhancement. The presence of confluent bone marrow edema within the olecranon tip beneath the bursal floor strongly supports contiguous osteomyelitis.

Bursal Fluid Aspiration and Analysis

Aspiration of bursal fluid is the diagnostic gold standard for any patient presenting with acute, warm, erythematous, or clinically ambiguous olecranon bursitis:

• Aspiration Technique: The elbow is positioned in 90 degrees of flexion. Following chlorhexidine skin antisepsis, a 18-gauge or 20-gauge needle attached to a 10-mL syringe is introduced strictly through a lateral or posterolateral approach traversing healthy, non-erythematous skin. Direct midline posterior puncture must be avoided to eliminate the risk of a persistent cutaneous sinus tract.
• Macroscopic Assessment: Clear, straw-colored fluid indicates non-inflammatory aseptic bursitis; bloody or serosanguinous fluid points to acute trauma; cloudy, turbid, or thick purulent aspirate indicates infection or acute tophaceous gout.
• Cell Count and Differential: Total leukocyte count and percentage of neutrophils. Aseptic bursitis typically yields fewer than 1,000 to 2,000 WBC/mcL with fewer than 50% PMNs. Septic bursitis typically produces greater than 10,000 to 50,000 WBC/mcL with greater than 80% to 90% PMNs. Marked overlap can occur in crystalline arthropathy, where WBC counts can exceed 50,000/mcL in the absence of infection.
• Microbiological Testing: Immediate Gram stain, followed by aerobic, anaerobic, and fungal/mycobacterial cultures. Gram stain demonstrates bacterial organisms in 50% to 70% of septic cases.
• Polarized Light Microscopy: Compensated polarized light microscopy must be performed on every aspirate to identify negatively birefringent, needle-shaped monosodium urate crystals (gout) or positively birefringent, rhomboid-shaped calcium pyrophosphate crystals (pseudogout).

7. Classification

A clinical staging classification links clinical presentation and microbiological status directly to algorithmic treatment pathways:

8. Treatment

Management of olecranon bursitis follows a structured, evidence-based algorithm determined by the presence of infection, chronicity, and soft-tissue integrity.

Nonoperative & Medical Management

Nonoperative therapy is the cornerstone of initial care, successfully resolving over 85% of aseptic cases:

• Mechanical Protection and Compression: Application of an elastic tubular compressive elbow sleeve or compressive figure-of-eight dressing limits bursal dead space and fluid reaccumulation. Patients must avoid resting the elbow on hard surfaces. Neoprene elbow pads with a central silicone doughnut are recommended for occupational mechanics, plumbers, and athletes.
• Pharmacotherapy: A 10- to 14-day course of oral non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, naproxen, or celecoxib reduces pain, synovial vascular permeability, and fluid exudation in aseptic and crystalline disease.
• Outpatient Oral Antimicrobial Regimens (Stage III): Oral agents with high bioavailability against methicillin-sensitive S. aureus and streptococci include cephalexin (500 mg orally every 6 hours) or dicloxacillin (500 mg orally every 6 hours). In areas with high CA-MRSA prevalence or in patients with penicillin allergy, trimethoprim-sulfamethoxazole (1 to 2 double-strength tablets orally every 12 hours) or clindamycin (300 to 450 mg orally every 8 hours) is administered for 10 to 14 days.
• Inpatient Intravenous Antimicrobial Regimens (Severe Stage III or Systemic Toxicity): Intravenous cefazolin (1 to 2 g IV every 8 hours). If MRSA is suspected or the patient exhibits systemic toxicity, vancomycin (15 to 20 mg/kg IV every 12 hours with serum trough monitoring) or daptomycin (6 to 8 mg/kg IV once daily) is initiated. Transition to oral therapy is guided by clinical resolution of erythema and negative repeat cultures.

Corticosteroid Injections: Hazards and Evidence

The role of intrabursal corticosteroid injection in aseptic olecranon bursitis is highly controversial. Systematic review data demonstrate that while corticosteroid administration provides rapid short-term resolution, it introduces severe, disproportionate complications. Reported adverse event rates range from 10% to 38%, including permanent dermal atrophy, cutaneous hypopigmentation, chronic discharging sinus tracts, and secondary iatrogenic bacterial infection. Corticosteroids must never be injected if septic bursitis has not been definitively ruled out, and routine use in acute traumatic bursitis is strongly discouraged.

Operative Management & Surgical Techniques

The goals of surgery are complete excision of infected or chronically thickened bursal tissue, elimination of dead space, decompression of the posterior soft-tissue envelope, resection of irritating osteophytes, preservation of the triceps tendon insertion, and primary tension-free wound healing.

• Patient Positioning and Surgical Incision: The patient is placed supine with the arm draped across the chest, or in the lateral decubitus position under sterile upper-arm tourniquet control. A gently curved posterolateral incision is marked, positioned 1.5 cm lateral to the apex of the olecranon process. A straight midline posterior incision directly over the olecranon tip must be avoided because it places the scar under maximal tension during elbow flexion, creating high risks of wound breakdown, painful scar hypersensitivity, and persistent drainage.
• Flap Elevation and Bursal Excision: Full-thickness dermo-fascial flaps are elevated superficial to the bursal wall to preserve the subdermal vascular plexus. Circumferential dissection around the bursal sac is carried down to the deep floor. Dissection on the medial side must respect the cubital tunnel corridor; avoid blind cauterization near the medial epicondyle to safeguard the ulnar nerve.
• Preservation of the Triceps Insertion and Spur Resection: The deep wall of the bursa is intimately attached to the olecranon cortex and the distal triceps tendon insertion. Sharp subperiosteal peeling directly off the bone is executed, leaving the triceps tendon fibers intact. Resect any prominent posterior olecranon spur using an osteotome or rongeur, and smooth the bony surface with a bone rasp.
• Suction Drainage and Layered Closure: Copious low-pressure pulse lavage is completed. A closed suction mini-drain is placed within the bursal bed and exited through a separate lateral stab incision. The deep subcutaneous layer is approximated with absorbable monofilament sutures, and the skin is closed without tension using non-absorbable interrupted horizontal mattress sutures. A well-padded posterior splint is applied with the elbow maintained at 45 to 60 degrees of flexion for 5 to 7 days.
• One-Stage Versus Two-Stage Bursectomy: Historically, surgeons managed septic olecranon bursitis with a 2-stage approach: radical open excision, packing the wound open, and returning for delayed secondary closure. Level I evidence from the prospective randomized controlled trial by Uçkay et al. conclusively demonstrated that primary 1-stage bursectomy with closed suction drainage matches the eradication rate of 2-stage bursectomy (80% vs 87% cure rate, P = 0.58) while dramatically halving the median hospital stay (4 vs 7 days, P < 0.001). Primary 1-stage bursectomy is now the gold standard for septic bursitis, provided the overlying skin remains viable.
• Endoscopic Bursectomy Technique: Endoscopic bursectomy is an established minimally invasive alternative for chronic aseptic bursitis and selected non-phlegmonous septic cases. Two posterolateral portals (proximal lateral and distal lateral, positioned 2 to 3 cm from the olecranon tip) are established under low-pressure fluid or carbon dioxide insufflation. A 4.0-mm or 2.7-mm 30-degree arthroscope and a motorized shaver/radiofrequency wand are introduced. Advantages include smaller operative scars, lower rates of wound dehiscence, and faster return to active sports. Limitations include a technical learning curve, potential for fluid extravasation, and risk of incomplete excision in large calcified tophi.

Indications & Contraindications

Operative intervention is reserved for precise clinical scenarios:

Definitive Operative Indications:

• Failure of targeted antimicrobial therapy in septic bursitis, defined as progressive erythema, persistent purulent fluid reaccumulation, or failure of inflammatory markers to decline after 48 to 72 hours of appropriate intravenous antibiotics.
• Complicated Stage IV septic bursitis presenting with dermal necrosis, extensive soft-tissue phlegmon, spontaneous cutaneous fistulization, or suspected olecranon osteomyelitis.
• Chronic recurrent aseptic bursitis (Stage II) with more than 3 distinct episodes, or persistent symptoms lasting longer than 3 to 6 months despite rigorous conservative therapy, resulting in unacceptable functional or mechanical limitation.
• Severe symptomatic tophaceous gouty bursitis with impending skin ulceration or secondary mechanical impingement.

Contraindications to Bursectomy:

• Acute uncomplicated aseptic bursitis that has not undergone an adequate trial of conservative care.
• Uncontrolled systemic bacteremia or medical instability requiring resuscitation prior to elective or non-emergent soft-tissue surgery.
• Severe local cutaneous cellulitis in the absence of bursal abscess, where surgical incisions would transverse heavily infected, hyperemic tissues without clear purulent collection.

9. Outcome

Clinical outcomes in olecranon bursitis correlate closely with initial diagnostic accuracy and adherence to surgical principles.

Nonoperative Resolution Rates

Conservative management of acute aseptic bursitis resolves the condition in over 85% of cases without long-term functional impairment. In prospective evaluations of acute bursitis protocols, structured algorithmic aspiration, compressive therapy, and targeted antibiotic administration achieved a 91% resolution rate in acute septic cases without requiring radical inpatient operative excision.

Operative Outcomes and Functional Recovery

When operative intervention is required, bursectomy achieves definitive cure in 80% to 95% of patients. In the randomized trial by Uçkay et al., 1-stage bursectomy achieved an 80% primary cure rate compared to 87% in the 2-stage cohort, with identical long-term recurrence rates and significantly reduced morbidity. Recurrence following complete open or endoscopic bursectomy occurs in fewer than 5% to 10% of cases and is generally attributable to incomplete bursal excision, persistent mechanical trauma, or retained foreign bodies.

Patient-Reported Outcome Measures (PROMs)

Functional assessment using the Disabilities of the Arm, Shoulder and Hand (DASH) score and the Mayo Elbow Performance Score (MEPS) demonstrates excellent functional recovery following bursectomy. Mean postoperative DASH scores routinely score under 15 points, and MEPS values exceed 85 to 90 points, indicating excellent elbow motion, stability, and pain relief. Return to sedentary work is anticipated within 1 to 2 weeks postoperatively; return to strenuous manual labor or contact sports is permitted at 4 to 6 weeks, provided sound wound healing and full active extensor strength are verified.

10. Complications

Complications associated with olecranon bursitis and its treatment can be structured into immediate intraoperative, early postoperative, and late postoperative categories:

11. Pearls and Pitfalls

Mastering olecranon bursitis requires keen clinical judgment and meticulous surgical execution:

• Clinical Pearl: “The Lateral Aspiration Corridor”: Never insert a needle through the inflamed, thinned posterior midline directly over the apex of the olecranon. Always advance the needle through healthy lateral or posterolateral skin into the bursal cavity. This creates a subcutaneous tissue flap that seals automatically upon needle withdrawal, preventing persistent synovial leakage and chronic draining fistulae.
• Clinical Pearl: “The Range of Motion Differentiator”: When examining an acutely swollen, red, hot elbow, immediately evaluate passive pronation and supination with the elbow flexed at 90 degrees. If rotation is smooth and completely painless, you have ruled out intra-articular septic arthritis of the elbow with high reliability; the pathology is almost certainly isolated superficial bursitis.
• Clinical Pearl: “Curvilinear Posterolateral Incision”: Design the operative skin incision at least 1.5 cm lateral to the olecranon tip or curve it gently around the lateral border. A lateral incision preserves the medial cutaneous blood supply, prevents direct pressure on the scar when resting the forearm on a table, and dramatically reduces wound edge dehiscence during elbow flexion.
• Clinical Pearl: “Subperiosteal Peeling and Spur Rasping”: Dissect the deep bursal wall strictly subperiosteal to protect the triceps tendon insertion. Always inspect the posterior olecranon tip for an underlying traction enthesophyte; resect the spur flush with the cortical surface using an osteotome and smooth the bone with a fine rasp to eliminate the mechanical driver of recurrence.
• Clinical Pitfall: “Relying on Afebrile Status to Exclude Sepsis”: Never assume an acutely inflamed olecranon bursa is aseptic simply because the patient lacks fever, tachycardia, or systemic leukocytosis. Nearly half of all patients with culture-positive septic olecranon bursitis are afebrile on presentation. Aspiration with cell count and culture is mandatory whenever erythema and warmth are present.
• Clinical Pitfall: “The Hazard of Intrabursal Corticosteroid Injections”: Corticosteroids provide rapid symptomatic relief in aseptic bursitis, but the high rates of dermal atrophy, hypopigmentation, chronic cutaneous fistulization, and secondary bacterial infection make routine injection a dangerous practice. Reserve steroids strictly for chronic, biopsy-proven rheumatoid or crystalline bursitis failing all other modalities, and only after infection is completely ruled out.
• Clinical Pitfall: “Prolonged Postoperative Casting”: Immobilizing the elbow in a cast or splint for more than 7 to 10 days postoperatively leads to rapid capsular cross-linking and permanent flexion contracture. Immobilize only for 5 to 7 days in 45 to 60 degrees of flexion to allow wound edges to adhere, then initiate supervised active range of motion.

12. Current Controversies

Modern orthopaedic literature actively debates several clinical strategies in olecranon bursitis management:

Corticosteroid Injections in Aseptic Bursitis

The therapeutic ratio of intrabursal corticosteroid injection remains intensely contested. Proponents argue that corticosteroid instillation rapidly aborts painful synovial inflammation, reduces fluid accumulation, and accelerates return to work in manual laborers. However, comprehensive systematic reviews (such as Kaur et al. 2023) emphasize that corticosteroids induce an unacceptably high rate of cutaneous atrophy (10% to 38%), local soft-tissue necrosis, chronic sinus formation, and iatrogenic bacterial seeding. Given that compressive wrapping, NSAIDs, and activity modification achieve resolution in over 85% of cases without soft-tissue destruction, expert consensus strongly advises against routine corticosteroid injection for primary aseptic bursitis.

1-Stage Versus 2-Stage Bursectomy for Septic Bursitis

Historically, surgical dogma dictated that purulent bursitis must be treated like a superficial abscess: radical open bursectomy followed by packing the wound open for delayed secondary closure or prolonged secondary intention healing. This 2-stage approach imposed tremendous wound care burdens, frequent dressing changes, and prolonged hospitalization. The landmark Level I prospective randomized controlled trial by Uçkay et al. challenged this paradigm, proving that primary 1-stage bursectomy with closed suction drainage yields identical cure rates (80% vs 87%) without increasing recurrence, while cutting median hospital stays from 7 days down to 4 days. As long as the overlying skin is viable, 1-stage primary closure with closed suction drainage is now recognized as the standard of care.

Open Versus Endoscopic Bursectomy

Endoscopic bursectomy has gained substantial popularity as an alternative to open excision. Proponents emphasize smaller cosmetic puncture wounds, lower rates of wound edge dehiscence, and earlier resumption of full physical activity. Conversely, skeptics point out that endoscopic bursectomy requires specialized arthroscopic equipment, possesses a distinct learning curve, and carries risks of fluid extravasation, incomplete resection of large fibrous septae or tophaceous deposits, and thermal injury to the skin or triceps tendon. Most surgeons reserve endoscopic techniques for chronic aseptic bursitis with minimal skin compromise, while favoring open bursectomy for large tophi, prominent bony spurs requiring osteotomy, or complicated purulent septic bursitis.

13. Evidence-Based Synthesis

Modern clinical decision-making is grounded in high-quality randomized controlled trials and prospective registry analyses, corroborated by seminal biomechanical and anatomical descriptions.

14. References

• Uçkay I, von Dach E, Perez C et al. One- vs 2-Stage Bursectomy for Septic Olecranon and Prepatellar Bursitis: A Prospective Randomized Trial. Mayo Clin Proc. 2017. doi:10.1016/j.mayocp.2017.03.011 [Level I: Randomized Controlled Trial]
• Kaur IP, Mughal MS, Aslam F et al. Non-surgical treatment of aseptic olecranon bursitis: A systematic review. Reumatol Clin (Engl Ed). 2023. doi:10.1016/j.reumae.2023.05.004 [Level I: Systematic Review / Meta-Analysis]
• Sayegh ET, Strauch RJ. Treatment of olecranon bursitis: a systematic review. Arch Orthop Trauma Surg. 2014. doi:10.1007/s00402-014-2088-3 [Level I: Systematic Review / Meta-Analysis]
• Reilly D, Kamineni S. Olecranon bursitis. J Shoulder Elbow Surg. 2016. doi:10.1016/j.jse.2015.08.032 [Level V: Expert Comprehensive Review]
• Aaron DL, Patel A, Kayiaros S, Calfee R. Four Common Types of Bursitis: Diagnosis and Management. J Am Acad Orthop Surg. 2011. doi:10.5435/00124635-201106000-00006 [Level V: JAAOS Comprehensive Clinical Review]
• Stell IM. Management of acute bursitis: outcome study of a structured approach. J R Soc Med. 1999. doi:10.1177/014107689909201006 [Level IV: Prospective Cohort Study]

15. Master Class Pro-Tip

Master Class Pro-Tip: In recalcitrant septic or chronic tophaceous olecranon bursitis, surgical failure and chronic wound breakdown almost invariably stem from two technical errors: making a direct posterior midline skin incision and inadvertently violating the triceps insertion footprint during deep bursal excision. Always utilize a gently curved posterolateral incision situated 1.5 cm lateral to the olecranon apex, maintaining full-thickness dermo-fascial flaps to protect the tenuous posterior cutaneous microvasculature. When dissecting the deep bursal wall off the bone, execute sharp subperiosteal peeling directly on the cortical surface of the olecranon tip rather than cutting into the tendon substance, and thoroughly rasp down any prominent traction enthesophyte to eliminate posterior mechanical impingement. Following radical bursectomy and pulse lavage, close the deep fascia and skin primarily over a low-profile closed suction mini-drain brought out through a separate lateral stab site, and place the elbow in a well-padded posterior splint at 45 to 60 degrees of flexion for exactly 5 to 7 days: this immobilizes the skin envelope during the critical initial fibrin-sealing phase while preventing the severe extension-flexion contractures associated with prolonged casting.

Master Class Surgical Pearl: Surgical Management of Olecranon Bursitis